Efficacy of Interleukin-1β Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis
Efficacy of Interleukin-1β Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis
About this item
Full title
Author / Creator
Publisher
Dove
Journal title
Language
English
Formats
Publication information
Publisher
Dove
Subjects
More information
Scope and Contents
Contents
PurposeTo evaluate diacerein (interleukin-1β inhibitor) efficacy on ocular surface disease (OSD). Patients and MethodsThis prospective observational study included patients who received diacerein for osteoarthritis and had dry eye (DE). The primary outcome was corneal staining score. Secondary outcomes were ocular surface disease index (OSDI) score...
Alternative Titles
Full title
Efficacy of Interleukin-1β Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a446134204c24bc794e3f4d332350372
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a446134204c24bc794e3f4d332350372
Other Identifiers
ISSN
1177-5483,1177-5467
E-ISSN
1177-5483
DOI
10.2147/OPTH.S419310
